AI assistant
Sending…
PegBio Co., Ltd. — Share Issue/Capital Change 2002
Dec 31, 2002
50676_rns_2002-12-31_49275e76-29eb-4d2a-817b-242a670493eb.htm
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| HUNG FUNG GROUP<01141> - Odd Lot Arrangement The Stock Exchange has received a message from Hung Fung Group Holdings Limited which is reproduced as follows:- "In order to facilitate the trading of odd lots of the Reduced Shares as a result of the Share Consolidation and Capital Reduction, the Company will, commencing from the effective day of the Share Consolidation and Capital Reduction, appoint a broker as an agent to match, on a "best effort" basis, the sale and purchase of odd lots of the Reduced Shares arising from the Share Consolidation and Capital Reduction from 9:30 a.m. on 31st December, 2002 up to and including 4:00 p.m. on 11th February, 2003. Such arrangement is to facilitate Shareholders who wish to dispose of or top up their odd lots of Reduced Shares. Kingston Securities Limited has been appointed as such broker. Shareholders who wish to take advantage of this facility should contact Ms. Rosita Kiu of Kingston Securities Limited at Suite 2801, One International Finance Centre, 1 Harbour View Street, Central, Hong Kong (Tel: 2298 6215) during the period commencing from 31st December, 2002 up to and including 11th February, 2003. Shareholders are reminded that in order to effect the transaction, they will have to lodge with such broker the relevant share certificate(s) and duly signed and completed transfer form(s) and, if any, other documents of title. Shareholders should note that the matching of the sale and purchase of odd lots of Reduced Shares are not guaranteed. Shareholders are recommended to consult their stockbroker, other registered dealer in securities, bank manager, solicitor, professional accountant or other professional advisers if they are in any doubt about the facility described above." |
More from PegBio Co., Ltd.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 28
Share Issue/Capital Change
2026
Apr 9
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 2
Board/Management Information
2026
Apr 1
Earnings Release
2026
Mar 23
Regulatory Filings
2026
Mar 16
